Everest Medicines Limited (01952)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Blanchard Kerry Levan | 15-Feb-20 | 26-Aug-22 | CEO | ||
| Cho William Ki Chul | 12-Jan-24 | NED | |||
| Chui Hoi Yam | 19-Jan-23 | INED | |||
| Feng Honggang | 09-Feb-24 | 10-Oct-25 | NED | Resigned to devote more time to his other business endeavours. | |
| Fu Wei | 16-Jul-17 | Ch | |||
| Gong Yubo | 16-Jun-20 | 09-Feb-24 | NED | ||
| Jiang Shidong | 25-Sep-20 | INED | |||
| Kang Lan | 22-Dec-20 | 12-Jan-24 | NED | ||
| Lau Yee Wa | CoSec | ||||
| Li Yifan | 25-Sep-20 | INED | |||
| Liu Leah | 28-Mar-22 | CoSec | |||
| Luo Yongqing | 19-Sep-22 | CEO | |||
| Tan Bo | 25-Sep-20 | 19-Jan-23 | INED | ||
| Wei Fu | 10-Oct-25 | ED | Re-designated as a non-executive Director to devote more time to his other business endeavours. Fu has been appointed as the honorary chairman. | ||
| Woo Ian Ying | 16-Dec-18 | FD, Pres | |||
| Yin Yin | 31-Jan-22 | CoSec | |||
| Zhang Xiaofan | 16-Nov-17 | 31-Mar-23 | COO, ED |